Large cell neuroendocrine cell carcinoma of lung

large cell neuroendocrine carcinoma of the lung
LCNECs lung
undifferentiated large-cell carcinoma of the lung
Large cell neuroendocrine carcinomas
Large cell neuroendocrine carcinoma of the lungs
Large cell neuroendocrine carcinoma of lung
Large cell neuroendocrine carcinoma (LCNEC)
LCNEC lung
Large cell neuroendocrine cell carcinoma of the lung

Large cell neuroendocrine carcinoma (LCNEC) of the lung is classified as a subtype of large cell carcinoma of the lung. It is also classified as a pulmonary neuroendocrine tumor.
Epidemiology
The incidence peaks around the 6decade . There is an increased male predilection . They are rare and may accounts for ∼3% of all lung cancers, although the proportion of lung cancers diagnosed as large cell neuroendocrine carcinoma may be increasing .
Pathology
Large cell neuroendocrine carcinoma of the lung is poorly differentiated and high-grade neuroendocrine tumors .
They have neuroendocrine morphology, neuroendocrine differentiation on immunohistochemistry, often high mitotic rates (>10 mitoses/mm) and non-small cell cytological features .
As with other neuroendocrine cells of the lung, large cell neuroendocrine carcinoma arises from Kulchitsky cells of the bronchial mucosa .
Associations
There is a strong association with smoking .
Radiographic features
CT
CT features are non-specific. Large cell neuroendocrine carcinomas, in general, tend to present as oval-to-round and well-demarcated masses with lobulated margins. Their size typically ranges from 2 to 5 cm. Internal calcification is uncommon (9-21%) . A slight peripheral predilection may be present . There can be homogeneous or inhomogeneous enhancement following contrast .
Treatment and prognosis
They tend to be aggressive high-grade tumors with a poor prognosis . The overall prognosis is thought to be between that of an atypical pulmonary carcinoid and small cell lung cancer .
Siehe auch:
und weiter:
